See more : ScION Tech Growth II (SCOB) Income Statement Analysis – Financial Results
Complete financial analysis of MedTech Acquisition Corporation (MTACU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedTech Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- 6D Global Technologies, Inc. (SIXD) Income Statement Analysis – Financial Results
- J D Wetherspoon plc (JDWPY) Income Statement Analysis – Financial Results
- Wentworth Resources plc (WEN.L) Income Statement Analysis – Financial Results
- Ratio Petroleum Energy – Limited Partnership (RTPT.TA) Income Statement Analysis – Financial Results
- Zhejiang Huada New Materials Co., Ltd. (605158.SS) Income Statement Analysis – Financial Results
MedTech Acquisition Corporation (MTACU)
Industry: Shell Companies
Sector: Financial Services
About MedTech Acquisition Corporation
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 18.51M | 12.40M | 8.40M | 5.43M |
| Cost of Revenue | 2.61M | 2.26M | 1.19M | 2.20M |
| Gross Profit | 15.91M | 10.14M | 7.21M | 3.24M |
| Gross Profit Ratio | 85.93% | 81.79% | 85.80% | 59.55% |
| Research & Development | 29.51M | 21.36M | 14.22M | 15.83M |
| General & Administrative | 23.51M | 12.48M | 8.75M | 6.87M |
| Selling & Marketing | 17.03M | 12.74M | 8.26M | 6.19M |
| SG&A | 40.55M | 25.22M | 17.02M | 13.06M |
| Other Expenses | 0.00 | -8.73M | 746.00K | 0.00 |
| Operating Expenses | 70.06M | 46.58M | 31.24M | 29.02M |
| Cost & Expenses | 72.66M | 48.84M | 32.43M | 31.22M |
| Interest Income | 431.00K | 180.00K | 64.00K | 0.00 |
| Interest Expense | 16.00K | 1.00K | 1.76M | 0.00 |
| Depreciation & Amortization | 702.00K | 414.00K | 464.00K | 321.00K |
| EBITDA | -58.30M | -46.76M | -23.57M | -25.33M |
| EBITDA Ratio | -314.94% | -359.68% | -271.66% | -466.05% |
| Operating Income | -54.15M | -36.44M | -24.03M | -25.65M |
| Operating Income Ratio | -292.53% | -293.91% | -286.06% | -471.95% |
| Total Other Income/Expenses | -4.88M | -10.74M | -4.81M | -6.18M |
| Income Before Tax | -59.03M | -47.18M | -28.84M | -31.83M |
| Income Before Tax Ratio | -318.89% | -380.53% | -343.32% | -585.68% |
| Income Tax Expense | 9.00K | 9.00K | 3.00K | 4.00K |
| Net Income | -59.04M | -47.19M | -28.85M | -31.83M |
| Net Income Ratio | -318.93% | -380.60% | -343.35% | -585.76% |
| EPS | -6.73 | -1.59 | -0.92 | -1.04 |
| EPS Diluted | -6.73 | -1.59 | -0.92 | -1.04 |
| Weighted Avg Shares Out | 9.40M | 29.61M | 31.25M | 30.56M |
| Weighted Avg Shares Out (Dil) | 9.40M | 29.61M | 31.25M | 30.56M |
Magnetar Financial LLC Reduces Stake in MedTech Acquisition Corp
MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021
MedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public Offering
Source: https://incomestatements.info
Category: Stock Reports